Author

Aldo Trylesinski 1

1 Intercept Pharmaceuticals, Inc.,San Diego,United States

TREATMENT WITH OBETICHOLIC ACID IN PATIENTS WITH NASH DOES NOT SHOW INCREASED MARKERS OF LIVER TOXICITY BASED ON EVALUATION OF DRUG-INDUCED SERIOUS HEPATOTOXICITY (EDISH)

Arun J Sanyal, Paul Pockros, Amrik Shah, Reshma Shringarpure, David Shapiro, Aldo Trylesinski, Leigh MacConell

Item 1 - 1 / 1
1